Filing Details
- Accession Number:
- 0001209191-11-057409
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-21 17:22:36
- Reporting Period:
- 2011-11-18
- Filing Date:
- 2011-11-21
- Accepted Time:
- 2011-11-21 17:22:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 910267 | Titan Pharmaceuticals Inc | TTNP.OB | Biological Products, (No Disgnostic Substances) (2836) | 943171940 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1412377 | Marc Rubin | 400 Oyster Point Blvd., Suite 505 So. San Francisco CA 94080 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | Acquisiton | 2011-11-18 | 38,400 | $1.27 | 413,400 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
